Informed consent: Are we doing enough?
2010

Improving the Informed Consent Process in Clinical Trials

publication Evidence: moderate

Author Information

Author(s): Pranati

Primary Institution: Institute for One World Health

Hypothesis

Are we doing enough to ensure informed consent in clinical trials?

Conclusion

The informed consent process often fails to ensure true understanding and autonomy among participants, especially in populations with low literacy and medical awareness.

Supporting Evidence

  • The informed consent process is often reduced to just obtaining signatures without ensuring understanding.
  • Many participants in clinical trials believe they are receiving effective treatments, which can lead to withdrawal of consent if expectations are not met.
  • Barriers such as language and cultural differences complicate the informed consent process.
  • Community involvement in developing consent materials can improve understanding among participants.

Takeaway

When people agree to join a study, they often just sign a paper without really understanding what it means, especially if they don't know much about medicine. We need to make sure they really understand what they're agreeing to.

Potential Biases

Potential bias due to the assumption that all participants have a similar level of understanding and awareness.

Limitations

The study highlights barriers such as low literacy, cultural differences, and the complexity of consent forms that hinder understanding.

Participant Demographics

The study discusses a diverse population in India, including a significant portion that is illiterate and medically naïve.

Digital Object Identifier (DOI)

10.4103/2229-3485.71769

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication